U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07829861) titled 'The Effects of an Orally-Administered Probiotic on Vaginal Symptoms' on Sept. 15.
Brief Summary: This randomized, double-blind, placebo-controlled, virtual trial is designed to determine the efficacy of an orally-administered probiotic on alleviating vaginal odor and other vaginal symptoms. Eligibility is determined by the presence of vaginal symptoms. Participation in the trial lasts approximately 75 days; during 15 of these days, participants consume a capsule containing the active form of the probiotic or a placebo. Participants complete weekly questionnaires with items pertaining to their subjective vaginal health as well as a ...